Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-08-12 Sale |
2020-08-14 6:47 pm |
ENDOLOGIX INC | ELGX | Thompson Matthew Chief Medical Officer |
21,888 | $0.088 | $1,926 | 52,878 (Direct) |
View |
2020-08-05 Sale |
2020-08-07 8:09 pm |
ENDOLOGIX INC | ELGX | Thompson Matthew Chief Medical Officer |
33,850 | $0.00705 | $239 | 74,766 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-06-20 Option Award |
2024-06-28 8:53 pm |
N/A 2029-06-20 |
Vivos Therapeutics Inc. | VVOS | Thompson Matthew Director |
4,000 | $2.38 | 7,067 (Direct) |
View |
2022-12-23 Option Award |
2022-12-28 9:45 pm |
N/A 2027-12-23 |
Vivos Therapeutics Inc. | VVOS | Thompson Matthew Director |
30,000 | $0.48 | 76,667 (Direct) |
View |
2021-08-05 Option Award |
2021-08-10 9:49 pm |
N/A 2026-08-05 |
Vivos Therapeutics Inc. | VVOS | Thompson Matthew Director |
30,000 | $2.72 | 46,667 (Direct) |
View |
Ownership |
2020-12-10 9:54 pm |
N/A 2025-06-19 |
Vivos Therapeutics Inc. | VVOS | Thompson Matthew Director |
0 | $0 | 16,667 (Direct) |
View |